When Camryn Clements’ husband, an internal medicine doctor in training at the time, faced a series of health issues, the ...

The global fatty liver treatment market, valued at approximately USD 20 Billion in 2022, is anticipated to witness ...

We spoke to a a primary care physician for tips on how to prioritize our health as we age — from our 30s through our 70s and ...

In fact, more and more teens that meet certain weight and health criteria are going on GLP-1s after the FDA’s approval of ...

The study highlights BMI's role in mediating genetic risk for diseases, suggesting a complex relationship with conditions ...

In 2023, global liver disease medical societies and patient groups formalized the decision to rename non-alcoholic fatty liver disease (NAFLD) to metabolic dysfunction-associated steatotic liver ...

Unexplained fluctuations in cholesterol levels have been linked to dementia and cognitive decline in a recent study.

UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver disease associated with obesity and type 2 diabetes that affects more than ...

2 There are currently no treatments approved for MASLD, formerly known as nonalcoholic fatty liver disease. Instead, ...

Nonalcoholic fatty liver disease is the most common liver disease in America. If you have any of these fatty liver symptoms ...

Beer drinkers are more likely to have an unhealthy lifestyle than folks who prefer wine or liquor, scientists report.

Obesity, alcohol use and other factors are driving up rates of fatty liver disease among American adults, new research warns.